These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18073410)

  • 1. Metabolic control of proteasome function.
    Zhang F; Paterson AJ; Huang P; Wang K; Kudlow JE
    Physiology (Bethesda); 2007 Dec; 22():373-9. PubMed ID: 18073410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of proteasome in malignant diseases.
    Moran E; Nencioni A
    J BUON; 2007 Sep; 12 Suppl 1():S95-9. PubMed ID: 17935285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasome inhibition: mechanism of action.
    DeMartino GN
    J Natl Compr Canc Netw; 2004 Nov; 2 Suppl 4():S5-9. PubMed ID: 19791423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Change can happen" by PKA: proteasomes in in vivo hearts.
    Akazawa H; Komuro I
    J Mol Cell Cardiol; 2009 Apr; 46(4):445-7. PubMed ID: 19162036
    [No Abstract]   [Full Text] [Related]  

  • 5. [Proteasome and proteolysis].
    Papapostolou D; Reboud-Ravaux M
    J Soc Biol; 2004; 198(3):263-78. PubMed ID: 15662944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasome inhibition up-regulates p53 and apoptosis-inducing factor in chondrocytes causing severe growth retardation in mice.
    Zaman F; Menendez-Benito V; Eriksson E; Chagin AS; Takigawa M; Fadeel B; Dantuma NP; Chrysis D; Sävendahl L
    Cancer Res; 2007 Oct; 67(20):10078-86. PubMed ID: 17942942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physalin B, a novel inhibitor of the ubiquitin-proteasome pathway, triggers NOXA-associated apoptosis.
    Vandenberghe I; Créancier L; Vispé S; Annereau JP; Barret JM; Pouny I; Samson A; Aussagues Y; Massiot G; Ausseil F; Bailly C; Kruczynski A
    Biochem Pharmacol; 2008 Aug; 76(4):453-62. PubMed ID: 18577376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells.
    Nencioni A; Garuti A; Schwarzenberg K; Cirmena G; Dal Bello G; Rocco I; Barbieri E; Brossart P; Patrone F; Ballestrero A
    Eur J Immunol; 2006 Mar; 36(3):681-9. PubMed ID: 16479541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ubiquitin-proteasome system: focus on the heart.
    Zolk O; Schenke C; Sarikas A
    Cardiovasc Res; 2006 Jun; 70(3):410-21. PubMed ID: 16497285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of the ubiquitin proteasome system and its involvement in apoptosis.
    Melino G
    Cell Death Differ; 2005 Sep; 12(9):1155-7. PubMed ID: 16094390
    [No Abstract]   [Full Text] [Related]  

  • 11. Upregulation of immunoproteasomes by nitric oxide: potential antioxidative mechanism in endothelial cells.
    Kotamraju S; Matalon S; Matsunaga T; Shang T; Hickman-Davis JM; Kalyanaraman B
    Free Radic Biol Med; 2006 Mar; 40(6):1034-44. PubMed ID: 16540399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysfunction of the ubiquitin-proteasome system in multiple disease conditions: therapeutic approaches.
    Paul S
    Bioessays; 2008 Nov; 30(11-12):1172-84. PubMed ID: 18937370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-GlcNAc peptide epoxyketones are recognized by mammalian proteasomes.
    Witte MD; Florea BI; Verdoes M; Adeyanju O; Van der Marel GA; Overkleeft HS
    J Am Chem Soc; 2009 Sep; 131(34):12064-5. PubMed ID: 19658393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenylate cyclase regulation via proteasome-mediated modulation of Galphas levels.
    Naviglio S; Pagano M; Romano M; Sorrentino A; Fusco A; Illiano F; Chiosi E; Spina A; Illiano G
    Cell Signal; 2004 Nov; 16(11):1229-37. PubMed ID: 15337522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ubiquitins, proteasomes, sumoylation and therapeutic application today and in future for cancer and other diseases. I. Ubiquitin-proteasome system and the transcription factor NF-kappaB].
    Fuchs O; Neuwirtová R
    Vnitr Lek; 2006 Apr; 52(4):371-8. PubMed ID: 16755993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the ubiquitin-proteasome pathway with inorganic compounds to fight cancer: a challenge for the future.
    Dalla Via L; Nardon C; Fregona D
    Future Med Chem; 2012 Mar; 4(4):525-43. PubMed ID: 22416778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The vital link between the ubiquitin-proteasome pathway and DNA repair: impact on cancer therapy.
    Motegi A; Murakawa Y; Takeda S
    Cancer Lett; 2009 Sep; 283(1):1-9. PubMed ID: 19201084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Cidea protein stability by the ubiquitin-mediated proteasomal degradation pathway.
    Chan SC; Lin SC; Li P
    Biochem J; 2007 Dec; 408(2):259-66. PubMed ID: 17711404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin and ubiquitin-like proteins as multifunctional signals.
    Welchman RL; Gordon C; Mayer RJ
    Nat Rev Mol Cell Biol; 2005 Aug; 6(8):599-609. PubMed ID: 16064136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYC-induced sensitivity of human malignant melanoma to proteasome inhibitors - a KaMYCaze effect.
    Fuchs SY
    Pigment Cell Melanoma Res; 2008 Feb; 21(1):9-10. PubMed ID: 18353138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.